Granisetron is used for the prevention and treatment of nausea and vomiting induced by chemotherapy and radiotherapy; it is a highly selective 5-HT3 receptor antagonist with antiemetic potency 6–11 times greater than ondansetron; it is commonly used in combination with corticosteroids (e.g., dexamethasone) to enhance antiemetic efficacy, particularly in both acute and delayed phases of chemotherapy-induced nausea and vomiting.